Interventional cardiology techniques for coronary artery disease.
This review updates and extends observations made in this journal in March 1988. The focus then was on percutaneous transluminal coronary angioplasty and the clinical results of its practical application. A concern was expressed that science lagged in solving the major problems of rethrombosis and restenosis. The NHLBI Bypass Angioplasty Revascularization Investigation (BARI) study was still in the planning phase. In 1991, the scene has changed. Interventional cardiology now embraces a multitude of different catheter devices--angioplasty, atherectomy, laser, stents. Basic scientists are increasingly involved in addressing the restenosis issue. Our national heart meetings are increasingly oriented towards molecular biology approaches to solving the remaining problems. The BARI trial has nearly completed patient entry, and we eagerly await its results. The cardiologist and surgeon are faced with increasingly complex decisions with respect to interventional technologies, involving not only whether to use them, but which ones.
Vlietstra
R E
RE
Cardiology Section, Watson Clinic, Lakeland, Florida 33804-5000.
Brenner
A S
AS
Browne
K F
KF
D015906:Angioplasty, Balloon, Coronary; D006328:Cardiac Catheterization; D003327:Coronary Disease / Q000601:surgery / Q000628:therapy*; D004867:Equipment Design; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D015607:Stents; D013523:Surgical Equipment